focus -WSS

focus

author：leisure time 2025-09-28 20:05:47 - browse：61586

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Naloxone nonprofit donates 200,000 doses after FDA approval

focus

WSS

For Cytokinetics, FDA rejection of heart drug would help, not hinder

FDA panel endorses Alnylam’s heart drug — after picking it apart

Diverse clinical trials: Why aren’t we there yet?

Will the IRA bring competition to the biologics market?

What to make of Biden’s latest efforts on cancer research

Naloxone nonprofit donates 200,000 doses after FDA approval

knowledge

focus

hotspot

Walensky prepares to leave CDC — and Congress — behind

PEPFAR is under serious threat — and so is global health

Supreme Court strikes down use of affirmative action

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Dobbs anniversary: the lost opportunity of abortion as health care

Why failed clinical trials don’t always spell doom for a new drug

Moonlake's readout produced a cash windfall. Risks remain

Police still searching for prisoner who escaped from NYC hospital

Bright Health sells Medicare Advantage business to Molina

South Korea throws huge K

focus

Food makers to regulators: Ultra

White House touts steps to stem shortages of cancer treatments

Why failed clinical trials don’t always spell doom for a new drug

Methadone doses haven’t kept up in the age of fentanyl

What to know about Virgin Galactic's 1st mission taking paying customers to space

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

focus

entertainment

hotspot

Wikipedia